ckd and semaglutide 🔴Cardiovascular outcomes with by severity of chronic kidney disease in type 2 diabetes: the FLOW trial⤵️ 🔹Semaglutide significantly reduced the risk of CV death/MI/stroke regardless of baseline severity in participants Taking the next step: the

These pathways not only prevent over-consumption by signalling satiety (that feeling of satisfaction that comes after eating), but they additionally trigger other biological pathways that allow your body to use the nutrients that come from food

Targeting ferroptosis as a novel approach to alleviate aortic dissection

BMI, Body mass index

This approach allows your body to acclimate to the medication's appetite-suppressing effects while your digestive system adapts simultaneously

Checking for non-hunger cues and analysing times when you may think youre hungry, such as during periods of boredom, stress, or even thirst, can also help curb unnecessary cravings

Such guidance (PDF provider updates) shows how PBMs communicate changes to clinicians, forcing them to re-engage affected patients